You are here: Industry Insights > API

News List

Sandoz and Austrian government to invest in European antibiotic manufacturing europeanpharmaceuticalreview
July 28, 2020
Sandoz plans to invest €150 million and the Austrian government €50 million into integrated antibiotic manufacturing operations at Kundl.
LGM Acquires Pharmaceutical Development & Manufacturing Unit of Nexgen contractpharma
July 28, 2020
Gains 150 employees and more than 100,000 square feet of fully equipped facilities.
PLI scheme guidelines evoke mix reviews from industry expresspharma
July 28, 2020
Some laud the measures taken by the government while others list aspects that should have been considered under the scheme's guidelines.
Pharma experts feel more drugs need price increase expresspharma
July 24, 2020
Recently, NPPA allowed 50 per cent price increase for heparin injection, which is also an essential medicine for the treatment of COVID-19 patients.
ChemWerth Files its 500th Drug Master File with FDA contractpharma
July 24, 2020
API supplier supports both large and small finished dosage companies worldwide.
Govt issues notification on PLI Scheme with a few amendments expresspharma
July 23, 2020
Under the PLI Scheme, the industry seeks clarity on the definition of greenfield projects.
Govt may allow 30 per cent import of chemicals/intermediates in PLI scheme expresspharma
July 22, 2020
In the next phase of the PLI scheme, the government has plans to incentivise excipient manufacturers.
Glenmark launches hypertension awareness symbol, endorsed by API and HSI expresspharma
July 20, 2020
Glenmark Pharmaceuticals has launched the world’s first hypertension awareness symbol, in collaboration with the Association of Physicians of India (API) and Hypertension Society of India (HSI).
Industry asks govt to take out minimum investment criteria from PLI scheme expresspharma
July 16, 2020
Pharma stakeholders believe that this modification in the scheme will benefit the industry, patients and the nation in the long run.
TIFAC releases report on status, issues, technology readiness and challenges in API production expresspharma
July 16, 2020
It was released along with a white paper on ‘Focused Interventions for ‘Make in India’: Post COVID 19’ which brought out the strengths, market trends, and opportunities in five sectors, including healthcare.